BlackRock Health Sciences Trust (NYSE:BME) Shares Cross Above 50 Day Moving Average – Here’s What Happened

BlackRock Health Sciences Trust (NYSE:BME)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $41.35 and traded as high as $42.35. BlackRock Health Sciences Trust shares last traded at $41.76, with a volume of 28,236 shares changing hands.

BlackRock Health Sciences Trust Stock Up 0.5%

The business has a 50 day moving average of $41.35 and a 200 day moving average of $38.80.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be paid a $0.2621 dividend. This represents a c) annualized dividend and a dividend yield of 7.5%. The ex-dividend date is Friday, March 13th.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. increased its position in BlackRock Health Sciences Trust by 285,436.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares in the last quarter. Shaker Financial Services LLC bought a new stake in BlackRock Health Sciences Trust in the second quarter worth $8,186,000. Invesco Ltd. grew its stake in shares of BlackRock Health Sciences Trust by 7.6% in the third quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after acquiring an additional 15,381 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of BlackRock Health Sciences Trust by 18.8% during the third quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares in the last quarter. Finally, Royal Bank of Canada raised its position in shares of BlackRock Health Sciences Trust by 0.5% in the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after purchasing an additional 684 shares during the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.